{
    "url_original": "https://www.wsj.com/articles/u-s-adds-chinas-wuxi-biologics-to-unverified-list-shares-dive-11644295609?mod=business_featst_pos1",
    "url": "u-s-adds-chinas-wuxi-biologics-to-unverified-list-shares-dive-11644295609",
    "title": "U.S. Adds China’s Wuxi Biologics to ‘Unverified List’; Shares Dive",
    "sub_head": "Listing restricts an entity’s ability to receive U.S. exports",
    "category_1": "Markets",
    "time": "2022-02-08 03:55:00",
    "body": "HONG KONG—The shares of one of China’s most valuable biotechnology companies plummeted Tuesday, losing almost a quarter of their value after the U.S. Commerce Department flagged concerns about the firm to American exporters.<br />Two units of Wuxi Biologics (Cayman) Inc., a Jiangsu-headquartered firm whose stock is listed in Hong Kong, were among 33 Chinese organizations that were added to an “unverified list” by the Commerce Department on Monday."
}